- Home
- TYRA vs LMNR Comparison
TYRA vs LMNR Comparison
Compare TYRA & LMNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TYRA
- LMNR
- Stock Information
- Founded
- TYRA 2018
- LMNR 1893
- Country
- TYRA United States
- LMNR United States
- Employees
- TYRA N/A
- LMNR N/A
- Industry
- TYRA Biotechnology: Pharmaceutical Preparations
- LMNR Farming/Seeds/Milling
- Sector
- TYRA Health Care
- LMNR Consumer Staples
- Exchange
- TYRA Nasdaq
- LMNR Nasdaq
- Market Cap
- TYRA 422.6M
- LMNR 440.5M
- IPO Year
- TYRA 2021
- LMNR N/A
- Fundamental
- Price
- TYRA $8.92
- LMNR $16.02
- Analyst Decision
- TYRA Strong Buy
- LMNR Hold
- Analyst Count
- TYRA 6
- LMNR 1
- Target Price
- TYRA $30.50
- LMNR $23.00
- AVG Volume (30 Days)
- TYRA 353.6K
- LMNR 76.9K
- Earning Date
- TYRA 05-08-2025
- LMNR 06-05-2025
- Dividend Yield
- TYRA N/A
- LMNR 1.88%
- EPS Growth
- TYRA N/A
- LMNR N/A
- EPS
- TYRA N/A
- LMNR 0.43
- Revenue
- TYRA N/A
- LMNR $186,077,000.00
- Revenue This Year
- TYRA N/A
- LMNR N/A
- Revenue Next Year
- TYRA N/A
- LMNR $11.90
- P/E Ratio
- TYRA N/A
- LMNR $37.49
- Revenue Growth
- TYRA N/A
- LMNR 2.39
- 52 Week Low
- TYRA $6.42
- LMNR $15.58
- 52 Week High
- TYRA $29.60
- LMNR $29.22
- Technical
- Relative Strength Index (RSI)
- TYRA 45.95
- LMNR 31.61
- Support Level
- TYRA $8.23
- LMNR $15.76
- Resistance Level
- TYRA $8.80
- LMNR $16.90
- Average True Range (ATR)
- TYRA 0.70
- LMNR 0.78
- MACD
- TYRA 0.19
- LMNR 0.06
- Stochastic Oscillator
- TYRA 75.30
- LMNR 16.67
About TYRA Tyra Biosciences Inc.
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.
About LMNR Limoneira Co
Limoneira Co is an agribusiness company. The company's operating segments include Fresh Lemons; Lemon Packing; Avocados and Other Agribusiness. It generates maximum revenue from the Fresh Lemons segment.